Compounds > myristamidopropyl dimethylamine
Page last updated: 2024-11-08

myristamidopropyl dimethylamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

myristamidopropyl dimethylamine: antimicrobial solution [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID170759
SCHEMBL ID94326
MeSH IDM0353681

Synonyms (36)

Synonym
myristamidopropyl dimethylamine
FT-0661482
AKOS003262148
n-[3-(dimethylamino)propyl]tetradecanamide
aldox
n,n-dimethyl-(3-tetradecylamidopropyl)amine
tetradecanamide, n-(3-(dimethylamino)propyl)-
m-dimethylamine
myristic 3-dimethylaminopropylamide
dimethylaminopropyl myristamide
einecs 256-214-1
n-(3-(dimethylamino)propyl)tetradecanamide
unii-yxs2x34v8w
n-(3-(dimethylamino)propyl)myristamide
45267-19-4
yxs2x34v8w ,
n-[3-(dimethylamino)propyl]myristamide
schercodine m
STL377897
tetradecanamide, n-[3-(dimethylamino)propyl]-
SCHEMBL94326
IFYDWYVPVAMGRO-UHFFFAOYSA-N
n,n-dimethyl-n'-tetradecanoyl-1,3-propylenediamine
schercodine m amido-amine
myristamidopropyl dimethylamine [inci]
DTXSID2068470
c19h40n2o
AS-63490
SY032069
mfcd02029644
Q27294767
S10671
EN300-258626
CS-0152224
AC-36417
mapd
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (25)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (4.00)18.2507
2000's12 (48.00)29.6817
2010's10 (40.00)24.3611
2020's2 (8.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.37 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index5.16 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (15.38%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (3.85%)4.05%
Observational1 (3.85%)0.25%
Other20 (76.92%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
betaine
glycine betaine : The amino acid betaine derived from glycine.		2.0710amino-acid betaine;
glycine derivative		fundamental metabolite
alexidine
alexidine: until June 1975 was mistakenly treated as synonym for chlorhexidine; RN given refers to parent cpd. alexidine : An amphipathic bisbiguanide with a structure consisting of two (2-ethylhexyl)guanide units linked by a hexamethylene bridge.		5.6732biguanidesantibacterial agent
biguanides
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.. biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.		7.34114guanidines
3-hydroxybutanal
[no description available]		2.610
fluorescein
Fluorescein: A phthalic indicator dye that appears yellow-green in normal tear film and bright green in a more alkaline medium such as the aqueous humor.. fluorescein (lactone form) : A xanthene dye that is highly fluorescent, detectable even when present in minute quantities. Used forensically to detect traces of blood, in analytical chemistry as an indicator in silver nitrate titrations and in microscopy.		3.45112-benzofurans;
gamma-lactone;
organic heteropentacyclic compound;
oxaspiro compound;
polyphenol;
xanthene dye		fluorescent dye;
radioopaque medium
cocamidopropyl betaine
cocamidopropyl betaine: structure given in first source; Genagen CAB, Tego Betain, Rewoteric AMB 14 usually contain 30% cocamidopropyl betaine (CAPB). cocamidopropyl betaine : A mixture of carboxamidopropyl betaines derived from fatty acids of varying chain lengths. The principal component is lauramidopropyl betaine.. lauramidopropyl betaine : An ammonium betaine in which the the ammonium nitrogen is substituted by two methyl groups and a lauramidopropyl group. It is the major (>50%) component of cocamidopropyl betaine.		2.0710ammonium betainesurfactant
vantocil
polihexanide: RN given refers to parent cpd		5.6192
cobalt
Cobalt: A trace element that is a component of vitamin B12. It has the atomic symbol Co, atomic number 27, and atomic weight 58.93. It is used in nuclear weapons, alloys, and pigments. Deficiency in animals leads to anemia; its excess in humans can lead to erythrocytosis.. cobalt(1+) : A monovalent inorganic cation obtained from cobalt.. cobalt atom : A cobalt group element atom that has atomic number 27.		2.610cobalt group element atom;
metal allergen		micronutrient
povidone-iodine
Povidone-Iodine: An iodinated polyvinyl polymer used as topical antiseptic in surgery and for skin and mucous membrane infections, also as aerosol. The iodine may be radiolabeled for research purposes.		2.0310
chlorhexidine
Chlorhexidine: A disinfectant and topical anti-infective agent used also as mouthwash to prevent oral plaque.. chlorhexidine : A bisbiguanide compound with a structure consisting of two (p-chlorophenyl)guanide units linked by a hexamethylene bridge.		2.0110biguanides;
monochlorobenzenes		antibacterial agent;
antiinfective agent
4-hydroxymercuribenzoate
[no description available]		2.0510
galyfilcon a
galyfilcon A: used in soft contact lenses		2.0510
ConditionIndicatedRelationship StrengthStudiesTrials
Bacterial Eye Infections
[description not available]		02.7630
Corneal Diseases
Diseases of the cornea.		03.4811
Abscess, Amebic
[description not available]		02.1110
Keratitis, Acanthamoeba
[description not available]		02.7230
Amebiasis
Infection with any of various amebae. It is an asymptomatic carrier state in most individuals, but diseases ranging from chronic, mild diarrhea to fulminant dysentery may occur.		02.1110
Acanthamoeba Keratitis
Infection of the cornea by an ameboid protozoan which may cause corneal ulceration leading to blindness.		02.7230
Keratitis
Inflammation of the cornea.		07.7430
Pink Eye
[description not available]		03.4311
Active Hyperemia
[description not available]		03.4311
Xerophthalmia
Dryness of the eye surfaces caused by deficiency of tears or conjunctival secretions. It may be associated with vitamin A deficiency, trauma, or any condition in which the eyelids do not close completely.		03.4311
Conjunctivitis
INFLAMMATION of the CONJUNCTIVA.		03.4311
Hyperemia
The presence of an increased amount of blood in a body part or an organ leading to congestion or engorgement of blood vessels. Hyperemia can be due to increase of blood flow into the area (active or arterial), or due to obstruction of outflow of blood from the area (passive or venous).		03.4311
Ametropia
[description not available]		03.4511
Refractive Errors
Deviations from the average or standard indices of refraction of the eye through its dioptric or refractive apparatus.		03.4511
Allergic Contact Dermatitis
[description not available]		02.0710
Cheilitis
Inflammation of the lips. It is of various etiologies and degrees of pathology.		02.0710
Dermatitis, Allergic Contact
A contact dermatitis due to allergic sensitization to various substances. These substances subsequently produce inflammatory reactions in the skin of those who have acquired hypersensitivity to them as a result of prior exposure.		02.0710
Eye Infections, Fungal
Infection by a variety of fungi, usually through four possible mechanisms: superficial infection producing conjunctivitis, keratitis, or lacrimal obstruction; extension of infection from neighboring structures - skin, paranasal sinuses, nasopharynx; direct introduction during surgery or accidental penetrating trauma; or via the blood or lymphatic routes in patients with underlying mycoses.		02.0110
Eye Infections, Parasitic
Mild to severe infections of the eye and its adjacent structures (adnexa) by adult or larval protozoan or metazoan parasites.		02.0110
Fungal Diseases
[description not available]		02.0310
Mycoses
Diseases caused by FUNGI.		02.0310
Ocular Infections
[description not available]		0210
Eye Infections
Infection, moderate to severe, caused by bacteria, fungi, or viruses, which occurs either on the external surface of the eye or intraocularly with probable inflammation, visual impairment, or blindness.		0210